Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;25(5):1398-1402.
doi: 10.1111/dom.14965. Epub 2023 Feb 14.

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

Joseph M Kim  1 , Deepak L Bhatt  2 , Samuel Dagogo-Jack  3 , David Z I Cherney  4 , Francesco Cosentino  5 , Darren K McGuire  6 , Richard E Pratley  7 , Chih-Chin Liu  8 , Nilo B Cater  9 , Robert Frederich  10 , James P Mancuso  10 , Christopher P Cannon  1
Affiliations

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

Joseph M Kim et al. Diabetes Obes Metab. 2023 May.
No abstract available

Keywords: REDUCE-IT; VERTIS CV; cardiovascular risk reduction; icosapent ethyl; type 2 diabetes.

PubMed Disclaimer

References

REFERENCES

    1. American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S144-S174.
    1. Shah A, Isath A, Aronow WS. Cardiovascular complications of diabetes. Expert Rev Endocrinol Metab. 2022;17(5):383-388.
    1. Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255-323.
    1. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459-2502.
    1. Nichols GA, Philip S, Reynolds K, Granowitz CB, Fazio S. Increased cardiovascular risk in hypertriglyceridemic patients with statin-controlled LDL cholesterol. J Clin Endocrinol Metab. 2018;103(8):3019-3027.

Publication types

MeSH terms

Substances

LinkOut - more resources